pain

stop shut down close end button
Biotech

Lundbeck slashes value of $250M Abide buyout after pain setback

Lundbeck is slashing the book value of its $250 million Abide buyout in response to phase 1 data that triggered an early end to a pain program.
Nick Paul Taylor Oct 24, 2024 7:20am
Graphic of two hands shaking under a red and purple light

Polyrizon pays $3M for license to SciSparc's CB2R agonist

Aug 19, 2024 5:27am
A concept image to illustrate mental health medications Models of a pink brain and two white pills which are about the size

The neural circuits behind the placebo effect

Jul 24, 2024 9:02am
Pill bottle with pills shaped into question mark

AI may influence whether you can get pain medication

Aug 31, 2023 9:25am
An artists concept of spinal pain A silhouette of a person stands holding their back The spinal cord is highlighted on the

Gene therapy reduces chronic pain and chemo-induced neuropathy

Jul 31, 2023 9:30am
graphic of a saw cutting off the branch of a tree with employees on it resembling axing staff

Heron lays off 25% of staff in second round of cuts in 13 months

Jul 24, 2023 12:44pm